PMDA drug package insert

小児用レルベア50エリプタ14吸入用

PMDA Prescription drug · グラクソ・スミスクライン株式会社 · package insert Aug 23, 2024

Key facts

Brand names 小児用レルベア50エリプタ14吸入用, 小児用レルベア50エリプタ30吸入用, レルベア100エリプタ14吸入用, レルベア100エリプタ30吸入用, レルベア200エリプタ14吸入用, レルベア200エリプタ30吸入用
Nonproprietary names ビランテロールトリフェニル酢酸塩・フルチカゾンフランカルボン酸エステル
Companies 製造販売元/グラクソ・スミスクライン株式会社
Product type Prescription drug
Therapeutic category 喘息・COPD治療配合剤; 喘息治療配合剤
Therapeutic category codes 87229
YJ codes 2290803G5023, 2290803G6020, 2290803G1028, 2290803G3020, 2290803G2024, 2290803G4027
Approval numbers 30600AMX00146, 30600AMX00145, 22500AMX01811, 22500AMX01812, 22500AMX01813, 22500AMX01814
Package insert edition 第3版
Package insert date Aug 23, 2024
PMDA document key 340278_2290803G1028_1
PMDA company code 340278

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • Yes PMDA review report published
  • Yes Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)